DOI QR코드

DOI QR Code

비침습 유방암의 양·한방 협진 표준임상경로 모형 개발

Development of Clinical Pathway Model in Integrative Korean Medicine: Treatment of Non-invasive Breast Cancer

  • 조수연 (대전대학교 한의과대학) ;
  • 고성규 (경희대학교 한의과대학 예방의학교실) ;
  • 박선주 (대전대학교 한의과대학 예방의학교실)
  • Cho, Suyeon (College of Korean Medicine, Daejeon University) ;
  • Ko, Seong-Gyu (Department of Preventive Medicine, College of Korean Medicine, Kyung Hee University) ;
  • Park, Sunju (Department of Preventive Medicine, College of Korean Medicine, Daejeon University)
  • 투고 : 2022.04.12
  • 심사 : 2022.04.20
  • 발행 : 2022.04.30

초록

Objectives : The aim of this study was to develop a clinical pathway (CP) model for the integrative treatment of non-invasive breast cancer, with western medicine and Korean traditional medicine. Methods : The checklist model was composed in four types according to the target patients: DCIS inpatients, DCIS outpatients, LCIS inpatients, LCIS outpatients. The vertical axis of the pathway consists of 11 categories of actions applied to the patient. The horizontal axis was in accordance with the flow of time, comprising three periods during inpatient care and seven periods during outpatient care. In addition, CP was also composed in flow chart form. The pathway model was developed through a literature review of clinical practice guidelines, conference publications, papers, books, and websites. Results : The integrative CP model for non-invasive breast cancer was developed. Conclusions : The goal of the CP suggested in this study was to improve non-invasive breast cancer patients' quality of life and to supplement conventional treatment, by alleviating the side effects. The model developed through this study could serve as the basis when developing CPs in a real-world integrative medical environment. This could lead to a reduction in cost and time for CP development, thus bringing about efficiency in the clinical setting.

키워드

과제정보

본 연구는 보건복지부의 재원으로 한국보건산업진흥원의 보건의료기술연구개발사업 지원에 의하여 이루어진 것임(HI18C2382).

참고문헌

  1. Badve SS, Gokmen-Polar Y. Ductal carcinoma in situ of breast: update 2019. Pathology. 2019;51(6):563-9. https://doi.org/10.1016/j.pathol.2019.07.005
  2. Wong SM, Stout NK, Punglia RS, Prakash I, Sagara Y, Golshan M. Breast cancer prevention strategies in lobular carcinoma in situ: A decision analysis. Cancer. 2017;123(14):2609-17. https://doi.org/10.1002/cncr.30644
  3. Korean Breast Cancer Society. 2020 Breast Cancer Facts & Figures [Internet]. Seoul: Korean Breast Cancer Society; 2020 [cited 2022 Jan 27]. 25p. Available from: https://www.kbcs.or.kr/journal/file/210107.pdf
  4. The Society of Korean Medicine Obstetrics and Gynecology. Breast Cancer Clinical Practice Guideline of Korean Medicine [Internet]. Gyeongsan: National Institute for Korean Medicine Development; 2021 [cited 2022 Jan 27]. 215p. Available from: https://nikom.or.kr/nckm/module/practiceGuide/view.do?guide_idx=152&menu_idx=14
  5. Park JM, You SJ, Choi SY, Moon G, Lyu YS. Survey of Motives for Visiting Oriental Medical Hospital and Satisfaction with Oriental Medical Care for Cancer Patients: Report of 22 Cases. J of Oriental Neuropsychiatry. 2014;26(1):23-38. https://doi.org/10.7231/JON.2015.26.1.023
  6. Lee YJ, Lee SY, Jung YH, Lee SY, Jang JB, Hwang DS. A Review on Randomized Controlled Clinical Study on Acupuncture Treatment of Breast Cancer Patients. J Korean Obstet Gynecol. 2016;29(1):78-91. https://doi.org/10.15204/JKOBGY.2016.29.1.078
  7. Lawal AK, Rotter T, Kinsman L, Machotta A, Ronellenfitsch U, Scott SD, Goodridge D, Plishka C, Groot G. What is a clinical pathway? Refinement of an operational definition to identify clinical pathway studies for a Cochrane systematic review. BMC Med. 2016;14:35. https://doi.org/10.1186/s12916-016-0580-z
  8. Korean Breast Cancer Society. 2019 The 9th Korean Clinical Practice Guideline for Breast Cancer [Internet]. Seoul: Korean Breast Cancer Society; 2019 [cited 2022 Jan 27]. 226p. Available from: https://www.kbcs.or.kr/sub02/sub02.html.
  9. Jabbour M, Newton AS, Johnson D, Curran JA. Defining barriers and enablers for clinical pathway implementation in complex clinical settings. Implement Sci. 2018;13(1):139. https://doi.org/10.1186/s13012-018-0832-8
  10. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Breast Cancer Ver 2.2022 [Internet]. Pennsylvania: NCCN; 2021 [cited 2021 Jan 27]. 244p. Available from: https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1419
  11. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Survivorship Ver 3.2021 [Internet]. Pennsylvania: NCCN; 2021 [cited 2021 Jan 27]. 291p. Available from: https://www.nccn.org/guidelines/guidelines-detail?category=3&id=1466
  12. The American Society of Breast Surgeons. Performance and Practice Guidelines for Breast-Conserving Surgery/Partial Mastectomy. Columbia: The American Society of Breast Surgeons; 2015 [cited 2022 Jan 27]. 4p. Available from: https://www.breastsurgeons.org/docs/statements/Performance-and-Practice-Guidelines-for-Breast-Conserving-Surgery-Partial-Mastectomy.pdf
  13. The American Society of Breast Surgeons. Performance and Practice Guidelines for Mastectomy. Columbia: The American Society of Breast Surgeons; 2015 [cited 2022 Jan 27]. 4p. Available from: https://www.breastsurgeons.org/docs/statements/Performance-and-Practice-Guidelines-for-Breast-Conserving-Surgery-Partial-Mastectomy.pdf
  14. Practice Guidelines for Preoperative Fasting and the Use of Pharmacologic Agents to Reduce the Risk of Pulmonary Aspiration: Application to Healthy Patients Undergoing Elective Procedures: An Updated Report by the American Society of Anesthesiologists Task Force on Preoperative Fasting and the Use of Pharmacologic Agents to Reduce the Risk of Pulmonary Aspiration. Anesthesiology. 2017;126(3):376-93. https://doi.org/10.1097/ALN.0000000000001452
  15. Chen J, Lv Q, Yu M, Zhang X, Gou J. Randomized clinical trial of Chinese herbal medications to reduce wound complications after mastectomy for breast carcinoma. Br J Surg. 2010;97(12):1798-804. https://doi.org/10.1002/bjs.7227
  16. Lee KW, Yoo HS, Lee JS, Lee NH. A Preliminary Study for Development of Clinical Practice Guidelines of Korean Medicine in Breast Cancer. J Korean Obstet Gyneco. 2016;29(2):47-65. https://doi.org/10.15204/JKOBGY.2016.29.2.047
  17. Lyman GH, Greenlee H, Bohlke K, Bao T, DeMichele AM, Deng GE, Fouladbakhsh JM, Gil B, Hershman DL, Cohen L, Mussallem DM, Mustian KM, Price E, Rafte S. Integrative Therapies During and After Breast Cancer Treatment: ASCO Endorsement of the SIO Clinical Practice Guideline. J Clin Oncol. 2018;36(25):2647-55. https://doi.org/10.1200/jco.2018.79.2721
  18. Oh KM, Kim BK. Study on the Association of PSQI, IQ, BDI and DSOM in the Insomnia Patients(1). J of Oriental Neuropsychiatry. 2009;20(3):89-119.
  19. Kim YW, Kim MS. The change of upper body functional fitness on lymph massage and resistance exercise by the type of surgery for breast cancer. The Korean Journal of Physical Education. 2010;49(1):491-7.
  20. Yeun EJ, Kim SY, So HS, Suh YO, Lee EN, Lee EJ, Sok SH, Park YH, Ryu EJ, Park YM, Baek MH, Son DO. Medical-Surgical Nursing I. 9th edition. Paju: Soomoonsa. 2019:316-382.
  21. Yeun EJ, Kim SY, Suh YO, Lee EN, Lee EJ, Sok SH, Park YH, Ryu EJ, Park YM, Baek MH, Son DO, Choi JY. Medical-Surgical Nursing II. 9th edition. Paju: Soomoonsa. 2019:1519-1524.
  22. The Society of Korean Medicine Obstetrics and Gynecology. Korean Medicine Obstetrics & Gynecology II. revised 4th edition. Seoul: EuiSeong-Dang Publishing. 2021:458-467.
  23. Korean Association of Traditional Oncology. Integrative Oncology of Korean Medicine. Paju: Koonja Publishing. 2013:335-353.
  24. Johnson BL, Gross J. Handbook of Oncology Nursing. Suh SR, So HS, Chung BY, Kim YO, Sohn SK, trans. Seoul: Hyunmoon Publishing. 2000:32-60.
  25. Abrams D, Well A. Integrative Oncology. Yoo HS, Cho CK, Lee YW, Jung IC, trans. Seoul: E Public. 2009:85-124;477-496;547-564.
  26. National Cancer Information Center. Breast Cancer [Internet]. Goyang; [updated 2019 Jul 8; cited 2022 Jan 17]. Available from: https://www.cancer.go.kr/lay1/program/S1T211C217/cancer/view.do?cancer_seq=4757&menu_seq=4773#go2
  27. American Cancer Society. Follow-up Care After Breast Cancer Treatment [Internet]. Georgia: The American Cancer Society medical and editorial content team; [updated 2022 Jan 5, cited 2022 Jan 19]. Available from: https://www.cancer.org/cancer/breast-cancer/living-as-a-breast-cancer-survivor/follow-up-care-after-breast-cancer-treatment.html
  28. MedlinePlus. Tests and visits before surgery [Internet]. Bethesda (MD): Campbell T; [reviewd 2020 Feb 11, cited 2022 Jan 26]. Available from: https://medlineplus.gov/ency/patientinstructions/000479.htm
  29. Seoul National University Hospital. Post-discharge precautions for breast surgery patients [Internet]. Seoul; [updated 2017 Sep 22, cited 2022 Jan 19]. Available from: http://www.snuh.org/board/B016/view.do?bbs_no=3611&pageIndex=1&restrictedBbsType=&viewType=&cate_cd=&searchKey=all&searchWord=
  30. Kim JH, Chae SY, Ko MJ, Jo MG, Jang JY, Kim JY, Kim HN, Park KJ, Hwang JM, Goo B, Park YC, Baek YH, Nam SS, Seo BK. A Study on the Development and Application of Korean Medical Critical Pathway of Lumbar Disc Herniation in Four Different Medical Associations. J Korean Med. 2021;42(3):1-8.
  31. Jaggers LD. Differentiation of critical pathways from other health care management tools. Am J Health Syst Pharm. 1996;53(3):311-3. https://doi.org/10.1093/ajhp/53.3.311
  32. Kim M, Han C. Development of a Critical Pathway for a Korean Medicine Hospital Inpatient with Stroke. J Korean Med. 2021;42:62-71. https://doi.org/10.13048/jkm.21015
  33. Oh KE, Bak WS, Yang HI, Han SS, Yoo MC, Park SC, LEE SC. Development of Clinical Pathway and Analysis of Clinical Patterns for Optimizing the Integrative Medical Service. J Korean Orient Med Diagn. 2012;16(2):23-31.
  34. Kim BJ, Shin BC, Hwang MS, Shin KM, Heo I, Lim KT, Park IH, Son DW, Hwang EH. An Integrative Care Model of Clinical Pathway Approach for Acute Pain after Back Surgery: A Protocol for Clinical Trial. J Korean Med Rehabil. 2017;27(4):111-9. https://doi.org/10.18325/jkmr.2017.27.4.111
  35. Hong M, Shim SH, Yoon SH, Choi JY, Kim YS. Development and Validity Test on Preliminary Critical Pathway of Integrative Medicine for Lung Cancer Patients Treated with Chemotherapy. Korean J Orient Int Med. 2017;38(6):917-29. https://doi.org/10.22246/jikm.2017.38.6.917
  36. Eom YJ, Kwon DH, Kim YN, Lee HW, Chung SY, Cho SH. A Pilot Study on Effects of Critical Pathway Application for Hwa-Byung. J of Oriental Neuropsychiatry. 2021;32(4):337-43.
  37. Choi SJ, Kim DI, Noh EJ. A Study on the Application of Standard Korean Medicine Clinical Pathway for Dysmenorrhea. J Korean Obstet Gynecol. 2022;35(1):75-90.
  38. Statistics Korea. number of new patients, relative frequency, crude incidence rate, age-standardized incidence rate: by 24 cancer types and gender [Internet]. Daejeon: Statistics Korea; 2022 [updated 2022 Jan 2019; cited 2022 Apr 8]. Available from: https://kosis.kr/statHtml/statHtml.do?orgId=117&tblId=DT_117N_A00022&vw_cd=&list_id=&seqNo=&lang_mode=ko&language=kor&obj_var_id=&itm_id=&conn_path=I2
  39. Ganz PA. Quality-of-life issues in patients with ductal carcinoma in situ. J Natl Cancer Inst Monogr. 2010;2010(41):218-22. https://doi.org/10.1093/jncimonographs/lgq029